Autophagy–Lysosome Pathway in Multiple System Atrophy Pathogenesis: The Best Is Yet to Come
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262010204 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Panagiota Mavroeidi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center of Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, …. Hauptthemen laut MEDLINE: Autophagy, Lysosomes, Multiple System Atrophy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Foundation for Research and Innovation, Multiple System Atrophy UK Trust, Multiple System Atrophy Coalition.
Abstract (Originalsprache)
Multiple lines of evidence extracted from human post-mortem brain material and cellular and animal models of concomitant proteinopathies cumulatively suggest that the neuronal protein α-Synuclein exerts a strong influence on the pathogenesis of neurodegenerative comorbidities, collectively termed α-Synucleinopathies. Accumulation of α-Synuclein-positive inclusions in neurons or oligodendrocytes is the main histopathological hallmark of Parkinson’s disease (PD) or multiple system atrophy (MSA), respectively. In addition, various pieces of data indicate that components of the autophagy-lysosomal pathway are altered in the context of α-Synucleinopathies. α-Synuclein itself is degraded by autophagy; however, aberrant protein conformations may impair lysosomal function. Genetic PD often involves components of the lysosome, including common genetic mutations in GBA1, which encodes for the lysosomal enzyme β-glucocerebrosidase. Alterations in lysosomal components that correlate with a commensurate increase in α-Synuclein deposition have been widely observed in PD brains. However, corresponding data in the context of MSA are emerging but remain less extensive than PD. In the current review, we focus on the pathological features as well as the impairments in the autophagy–lysosome pathway (ALP) that are associated with MSA and discuss the current challenges and future directions of therapeutic strategies targeting autophagy in experimental MSA-like models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
ORCID-Profile: Maria Xilouri
Förderung
- Hellenic Foundation for Research and Innovation
- Multiple System Atrophy UK Trust
- Multiple System Atrophy Coalition
- Michael J. Fox Foundation
- Brain Precision Greece 2.0 program
Zitieren
APA
Mavroeidi, P., & Xilouri, M. (2025). Autophagy–Lysosome Pathway in Multiple System Atrophy Pathogenesis: The Best Is Yet to Come. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010204
Vancouver
Mavroeidi P, Xilouri M. Autophagy–Lysosome Pathway in Multiple System Atrophy Pathogenesis: The Best Is Yet to Come. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010204
BibTeX
@article{Mavroeidi2025,
author = {Mavroeidi, Panagiota and Xilouri, Maria},
title = {Autophagy–Lysosome Pathway in Multiple System Atrophy Pathogenesis: The Best Is Yet to Come},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262010204}
}
EUVIMED